Autoimmune Disease: Budget-buster or Enlightened Solutions? (The coming epidemic and the new administration in Washington)

Journal Title: Archives of Community Medicine and Public Health - Year 2017, Vol 3, Issue 1

Abstract

A rising epidemic among Americans threatens to disrupt the new US administration’s promise of affordable health insurance for all. The epidemic consists of a dramatic and ongoing increase in the incidence of autoimmune diseases (AD) across the populations of nearly all Western countries, diagnosed under approximately 100 different disease labels, and currently estimated to afflict up to 50 million Americans. One potential reason for the epidemic appears to be autoimmune reactions in people to immune ‘triggers’ in foods, a prime example of which may be the newly described GMO foods’ antigenic glyphosate-induced misfolded proteins. An analysis was undertaken, using a case study approach, to compare the relative cost/benefit ratios of treating the oncoming AD epidemic among Americans using the standard medicine (SM) pharmaceutical immunosuppression drug treatment model as compared to treating AD using a functional medicine (FM) approach of probiotics, lifestyle modification and improved diet choices along with governmental regulations to reduce consumption of trigger foods. We conclude that, for the American people over the next 10 years, applying only SM could cost up to $2 trillion more than a potentially equally or more effective diagnosis and treatment program emphasizing FM and government action to reduce trigger food consumption and avoid confounding influences from industry. While these two models are not mutually exclusive, our analysis suggests that the US government has a series of difficult choices ahead which will impact both its population’s health and the affordability of their health insurance over the next decade and beyond.

Authors and Affiliations

Beecham James E, Seneff Stephanie

Keywords

Related Articles

Palliative Care for Cancer: A Public Health Challenge in India

Palliative care is an emerging discipline worldwide which focuses on improving the quality of life of patients with chronic life threatening condition like cancer. Globally, palliative care is sparsely distributed in dev...

Walking Distance to Tobacco Outlets in Vulnerable Areas Baltimore City: An Issue of Health Equity

Introduction: Health equity concerns related to tobacco use are significant in Baltimore City. We use spatial analytic techniques to understand the density of tobacco outlets by areas of socioeconomic vulnerability, and...

Life after Medicine: A Systematic Review of Studies of Physicians’ Adjustment to Retirement

Background: A physician’s decision to retire has personal and social consequences. While there has been growing interest in how individuals adjust to retirement, less is known about physicians’ adjustment to retirement....

My Child Doesn’t Need to be Vaccinated Because We Lead a Healthy Lifestyle: Compensatory Health Beliefs Predicting Intentions and Reported Child Vaccination

Background: In the past two decades negative attitudes towards vaccination has surfaced among parents. These concerns are related to safety, adverse effects, lifestyle and religious issues. The present study focuses on c...

How to control the Tuberculosis and HIV/AIDS dual epidemic

This review contains the novel approaches and innovations on how to control the Tuberculosis and HIV/AIDS dual epidemics. AIDS kills more than 8000 people every day worldwide. More than 5000 people die from TB every day....

Download PDF file
  • EP ID EP326553
  • DOI 10.17352/2455-5479.000022
  • Views 73
  • Downloads 0

How To Cite

Beecham James E, Seneff Stephanie (2017). Autoimmune Disease: Budget-buster or Enlightened Solutions? (The coming epidemic and the new administration in Washington). Archives of Community Medicine and Public Health, 3(1), 32-40. https://europub.co.uk/articles/-A-326553